| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/01/2012 | CN101037430B (-)-meptazinol double-ligand derivative and/or its salt and preparation method and usage |
| 07/31/2012 | US8232428 Polycationic compounds and uses thereof |
| 07/31/2012 | US8232426 N-[4-((S)-2-Propylamino-propyl)-phenyl]-4-trifluoromethoxy-benzenesulfonamide; Dipropyl-{2-[4-(4-trifluoromethoxy-benzenesulfonylmethyl)-phenyl]-ethyl}-dipropyl-amine salt, psychological, nervous system disorders such as schizophernia, bipolar, dyskinesias, tourette syndrome, depression, sleep disorder |
| 07/31/2012 | US8232417 Artemisinin derivatives with natural amino acids, peptides, and amino sugars for skin imperfections and infection in mammals |
| 07/31/2012 | US8232410 Benzimidazoles and pharmaceutical compositions thereof |
| 07/31/2012 | US8232409 Heterocyclic benzimidazoles as TRPM8 modulators |
| 07/31/2012 | US8232408 Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1H)pyridone, the preparation methods, compositions and applications thereof |
| 07/31/2012 | US8232407 Nitrogenous heterocyclic compounds with insecticidal activity, and the preparation and use thereof |
| 07/31/2012 | US8232406 c-MET protein kinase inhibitors |
| 07/31/2012 | US8232405 Benzylpiperizine compound |
| 07/31/2012 | US8232404 Pyridone GPR119 G protein-coupled receptor agonists |
| 07/31/2012 | US8232403 Bicyclic derivatives as CETP inhibitors |
| 07/31/2012 | US8232402 Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
| 07/31/2012 | US8232401 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 07/31/2012 | US8232391 Bicyclic pyrazole compounds as antibacterial agents |
| 07/31/2012 | US8232390 Pentacyclic indole derivatives as antiviral agents |
| 07/31/2012 | US8232387 Process for the preparation of cladribine |
| 07/31/2012 | US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 07/31/2012 | US8232379 Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence |
| 07/31/2012 | US8232322 High molecular weight polymers, devices and method for making and using same |
| 07/31/2012 | US8232321 Alkylene oxide derivative and skin external preparation containing the same |
| 07/31/2012 | US8232320 Antimicrobial nanoemulsion compositions and methods |
| 07/31/2012 | US8232319 Amino phosphate derivative and S1P receptor modulator having same as an active ingredient |
| 07/31/2012 | US8232318 Approaches to treat cancer using HB-EGF inhibitors |
| 07/31/2012 | US8232317 Method for increasing hair growth |
| 07/31/2012 | US8232316 Compounds and methods for delivery of prostacyclin analogs |
| 07/31/2012 | US8232315 Methods for treating drug addiction and improving addiction-related behavior |
| 07/31/2012 | US8232313 Pharmaceutical compositions containing 1-methyl-D-tryptophan |
| 07/31/2012 | US8232312 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 07/31/2012 | US8232311 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators |
| 07/31/2012 | US8232310 Targeting of EWS-FLI1 as anti-tumor therapy |
| 07/31/2012 | US8232309 Prodrugs of compounds that inhibit TRPV1 receptor |
| 07/31/2012 | US8232308 Methods for treating a disease in which Rho kinase is involved |
| 07/31/2012 | US8232307 Indane-amine derivatives, their preparation and use as medicaments |
| 07/31/2012 | US8232306 Methods for detecting sulfhydryl-containing compounds in a biological test sample |
| 07/31/2012 | US8232305 1-methyl-3-(2-oxo-2-octyloxyethyl)-1H-Imidazolium bromide; imidazolium ionic liquids and non-ionic or anionic surfactants; stable antimicrobial activity; preservation of personal care and cosmetic products |
| 07/31/2012 | US8232304 Antifungal formulations |
| 07/31/2012 | US8232303 Two-photon absorbing water soluble fluorescent probe as a near neutral pH indicator |
| 07/31/2012 | US8232302 Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters |
| 07/31/2012 | US8232300 Tricyclic amide compound |
| 07/31/2012 | US8232299 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 07/31/2012 | US8232298 Inhibitors of the interaction between MDM2 and P53 |
| 07/31/2012 | US8232297 Sulphonylpyrroles as inhibitors of HDACs novel sulphonylpyrroles |
| 07/31/2012 | US8232296 Salt 628 |
| 07/31/2012 | US8232295 Treating vascular events with statins by inhibiting PAR-1 and PAR-4 |
| 07/31/2012 | US8232294 Amino ester derivatives, sailts thereof and methods of use |
| 07/31/2012 | US8232293 Crystalline forms of a potent HCV inhibitor |
| 07/31/2012 | US8232292 Sulfonamide compound and crystal thereof |
| 07/31/2012 | US8232291 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 07/31/2012 | US8232290 P2X7R antagonists and their use |
| 07/31/2012 | US8232289 Spiropiperidine compounds as ORL-1 receptor antagonists |
| 07/31/2012 | US8232288 Substituted benzimidazoles, benzothiazoles and benzoxazoles |
| 07/31/2012 | US8232286 N-[1-(3-dimethylamino-4-formyl-phenyl)-3-pyridin-3-yl-4,5-dihydro-1H-pyrazolo[4,3-g]benzothiazol-7-yl]-acetamide; phosphatidylinositol-3-kinases (PI3-kinases) inhibitor; cell growth, differentiation and intracellular transport processes; antiproliferative, antiinflammatory agent; autoimmune diseases |
| 07/31/2012 | US8232285 Quinazolinone compounds and methods of use thereof |
| 07/31/2012 | US8232284 Heteroaryloxy quinazoline derivative |
| 07/31/2012 | US8232283 Raf inhibitors |
| 07/31/2012 | US8232281 Uses of DPP-IV inhibitors |
| 07/31/2012 | US8232280 Inhibitors of bruton'S tyrosine kinase |
| 07/31/2012 | US8232279 Pyrazolopyrimidine derivatives having biological activity on serotonin receptor 5-HT2c |
| 07/31/2012 | US8232278 Pyrido(3,2-D)pyrimidines and pharmaceutical compositions useful for treating hepatitis C |
| 07/31/2012 | US8232277 Tetra-O-substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use |
| 07/31/2012 | US8232276 Anhydrous topical skin preparations |
| 07/31/2012 | US8232275 2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and -pyrimidines as antiviral agents |
| 07/31/2012 | US8232274 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 07/31/2012 | US8232273 Heterocyclic compounds and methods of use |
| 07/31/2012 | US8232272 Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 07/31/2012 | US8232271 Heterocyclic antiviral compounds |
| 07/31/2012 | US8232270 Bivalent (−)-meptazinol compounds and/or their salts, and their preparation and futilization |
| 07/31/2012 | US8232269 Amide compounds useful in therapy |
| 07/31/2012 | US8232268 Carbapenem antibacterials with gram-negative activity and processes for their preparation |
| 07/31/2012 | US8232267 Porphyrin catalysts and methods of use thereof |
| 07/31/2012 | US8232266 Use of manzamine compounds in anti-cancer therapeutic regimens |
| 07/31/2012 | US8232265 Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients |
| 07/31/2012 | US8232264 Free of medium chain glycerides; topical delivery to skin; vehicle comprising at least two penetration enhancers such as propylene glycol, diisopropyl adipate, dimethyl isosorbide, 1,2,6-hexanetriol, and benzyl alcohol, as well as solvents and emulsifiers |
| 07/31/2012 | US8232263 17,20(Z)-dehydro vitamin D analogs and their uses |
| 07/31/2012 | US8232262 Hyperproliferative disorders; lyophilisates; shelf life; pharmacokinetics |
| 07/31/2012 | US8232260 In vivo production of small interfering RNAs that mediate gene silencing |
| 07/31/2012 | US8232259 Multiple CpG oligodeoxynucleotide and their use to induce an immune response |
| 07/31/2012 | US8232258 NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and variants thereof, and their use |
| 07/31/2012 | US8232254 Colchicine neoglycosides and methods for their synthesis and use |
| 07/31/2012 | US8232253 Treatment of lung cancer |
| 07/31/2012 | US8232062 EGFR mutations |
| 07/31/2012 | US8232053 EGFR mutations |
| 07/31/2012 | US8231914 Antioxidant compositions and methods thereto |
| 07/31/2012 | US8231910 Combining EDTA-sodium-metal complex(es) and the sodium selenite solution to from trace element soultuton to provide the solution to the animals |
| 07/31/2012 | US8231905 Gastric retained gabapentin dosage form |
| 07/31/2012 | US8231904 Multilayer tablet ; autoimmune disease; antidiabetic agents; rheumatic disorders; antiarthritic agents; psoriasis |
| 07/31/2012 | US8231903 Controlled release system |
| 07/31/2012 | US8231901 Opioid agonist formulations with releasable and sequestered antagonist |
| 07/31/2012 | US8231898 Controlled release hydrocodone formulations |
| 07/31/2012 | US8231897 Hydrostatic delivery system for controlled delivery of agent |
| 07/31/2012 | US8231888 Isoxazolines for controlling invertebrate pests |
| 07/31/2012 | US8231885 Compounds, formulations, and methods for ameliorating telangiectasis |
| 07/31/2012 | US8231879 Treatment of diseases caused by viral infection |
| 07/31/2012 | US8231871 Perorally administrable antimicrobial composition |
| 07/31/2012 | CA2703688C Use of bile acid or bile salt fatty acid conjugates |
| 07/31/2012 | CA2677691C Reducing side effects of tramadol |
| 07/31/2012 | CA2655212C 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
| 07/31/2012 | CA2653333C Zofenopril calcium |
| 07/31/2012 | CA2647158C Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto |